Coherus Oncology, Inc.
CHRS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $29 | -$238 | -$292 | -$287 |
| Dep. & Amort. | $5 | $4 | $4 | $3 |
| Deferred Tax | $0 | $0 | $0 | $9 |
| Stock-Based Comp. | $28 | $0 | $51 | $51 |
| Change in WC | $56 | -$37 | -$79 | $42 |
| Other Non-Cash | -$138 | $96 | $75 | $143 |
| Operating Cash Flow | -$20 | -$175 | -$241 | -$37 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | -$2 | -$1 |
| Net Acquisitions | $0 | $1 | $0 | $1 |
| Inv. Purchases | $0 | -$20 | -$127 | -$182 |
| Inv. Sales/Matur. | $15 | $158 | $0 | $181 |
| Other Inv. Act. | $215 | $6 | -$37 | -$137 |
| Investing Cash Flow | $230 | $145 | -$167 | -$138 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$223 | $0 | $50 | -$1 |
| Stock Issued | $1 | $74 | $6 | $41 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $35 | -$5 | -$2 | $12 |
| Financing Cash Flow | -$187 | $70 | $54 | $52 |
| Forex Effect | $0 | -$0 | $0 | $0 |
| Net Chg. in Cash | $23 | $39 | -$354 | -$124 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $103 | $64 | $418 | $542 |
| End Cash | $126 | $103 | $64 | $418 |
| Free Cash Flow | -$20 | -$175 | -$243 | -$39 |